Key points are not available for this paper at this time.
Artificial intelligence (AI) encompasses a broad spectrum of techniques that have been utilized by pharmaceutical companies for decades, including machine learning, deep learning, and other advanced computational methods. These innovations have unlocked unprecedented opportunities for the acceleration of drug discovery and delivery, the optimization of treatment regimens, and the improvement of patient outcomes. AI is swiftly transforming the pharmaceutical industry, revolutionizing everything from drug development and discovery to personalized medicine, including target identification and validation, selection of excipients, prediction of the synthetic route, supply chain optimization, monitoring during continuous manufacturing processes, or predictive maintenance, among others. While the integration of AI promises to enhance efficiency, reduce costs, and improve both medicines and patient health, it also raises important questions from a regulatory point of view. In this review article, we will present a comprehensive overview of AI's applications in the pharmaceutical industry, covering areas such as drug discovery, target optimization, personalized medicine, drug safety, and more. By analyzing current research trends and case studies, we aim to shed light on AI's transformative impact on the pharmaceutical industry and its broader implications for healthcare.
Building similarity graph...
Analyzing shared references across papers
Loading...
Dolores R. Serrano
Francis C. Luciano
Brayan J. Anaya
SHILAP Revista de lepidopterología
Pharmaceutics
Universidad Complutense de Madrid
University of Strathclyde
Banaras Hindu University
Building similarity graph...
Analyzing shared references across papers
Loading...
Serrano et al. (Mon,) studied this question.
www.synapsesocial.com/papers/69db423678a3e0e288685179 — DOI: https://doi.org/10.3390/pharmaceutics16101328